Graeme Clark Collection

Permanent URI for this collection

Search Results

Now showing 1 - 4 of 4
  • Item
    Thumbnail Image
    Continuing improvements in speech processing for adult cochlear implant patients
    Hollow, R. D. ; Dowell, R. C. ; Cowan, R. S. C. ; Skok, M. C. ; Pyman, B. C. ; Clark, Graeme M. ( 1995)
    The Cochlear 22-channel cochlear implant has employed a succession of improved speech-processing strategies since its first use in an adult patient in Melbourne in 1982. 1 The first patients received the F0F2 coding strategy developed by the University of Melbourne, in the Wearable Speech Processor (WSP). The F0F2 coding scheme presented the implant user with three acoustic features of speech. These were 1) the amplitude of the waveform, presented as the amount of current charge, 2) fundamental frequency (F0) or voice pitch, presented as rate of biphasic pulsatile stimulation, and 3) the spectral range of the second formant frequency (F2), which was represented by varying the site of stimulation along the electrode array.
  • Item
    Thumbnail Image
    Cochlear implants in children
    Clark, Graeme M. ( 1995)
    Cochlear implants are devices that are used to artificially excite hearing nerves with patterns of stimulation that convey speech information and environmental sounds when a person's inner ear has been destroyed by disease or not developed at birth. In this situation they cannot benefit from the amplification of sound with a hearing aid.
  • Item
    Thumbnail Image
    Habilitation issues in the management of children using the cochlear multiple-channel cochlear prosthesis
    Cowan, Robert S. C. ; Barker, Elizabeth J. ; Dettman, Shani J. ; Blamey, Peter J. ; RANCE, GARY ; Sarant, Julia Z. ; Galvin, Karyn L. ; Dawson, Pam W. ; Hollow, Rod ; Dowell, Richard C. ; PYMAN, BRIAN ; Clark, Graeme M. (Wien, 1994)
    Since 1985, a significant proportion of patients seen in the Melbourne cochlear implant clinic have been children. The children represent a diverse population, with both congenital and acquired hearing-impairments, a wide-range of hearing levels pre-implant, and an age range from 2 years to 18 years. The habilitation programme developed for the overall group must be flexible enough to be tailored to the individual needs of each child, and to adapt to the changing needs of children as they progress. Long-term data shows that children are continuing to show improvements after 5-7 years of device use, particularly in their perception of open-set words and sentences. Habilitation programs must therefore be geared to the long-term needs of children and their families. Both speech perception and speech production need to be addressed in the specific content of the habilitation program for any individual child. In addition, for young children, the benefits of improved speech perception should have an impact on development of speech and language, and the focus of the programme for this age child will reflect this difference in emphasis. Specific materials and approaches will vary for very young children, school-age and teenage children. In addition, educational setting will have a bearing on the integration of listening and device use into the classroom environment.
  • Item
    Thumbnail Image
    Latest results and future directions in speech processing for the Nucleus multichannel cochlear prosthesis [Abstract]
    Dowell, R. ; Whitford, L. ; Seligman, P. ; Vandali, A. ; Hollow, R. ; Clark, Graeme M. ( 1995)
    The past two years has seen the introduction of the Speak speech encoding scheme for most patients using the Nucleus 22-channel cochlear prosthesis. This scheme, based on the Spectral Maxima Speech Processor (SMSP) developed at the University of Melbourne, uses a bank of 20 band-pass filters to present detailed spectral information to the intracochlear electrode array. Clinical trials of this speech processor have shown highly significant improvements over the previous Multipeak scheme in English, German, French and Japanese speaking patients. The largest improvements were evident for open-set testing in background noise, which represents a more realistic measure of everyday benefit than testing in quiet. The latest results for adults who have changed from Multipeak to Speak will be presented, along with results over time for newly-implanted patients using the Speak scheme. New research aimed at improving the speech processing in both the spectral and temporal domains will also be discussed.